The Impact of Primary Tumor Volume on Survival of Patients with Non-Surgically Treated Advanced-Stage Hypopharyngeal Cancer- Retrospective Study and Literature Overview

被引:0
|
作者
Jakovljevic, Sasa [1 ,2 ]
Djordjevic, Vladimir [1 ,2 ]
Tomanovic, Nada [1 ,3 ]
Arsovic, Nenad [1 ,2 ]
Dudvarski, Zoran [1 ,2 ]
Ursulovic, Tamara [4 ]
Laketic, Darko [1 ,5 ]
Jovanovic, Katarina [2 ]
Arsovic, Konstantin [2 ]
Radivojevic, Nemanja [1 ,2 ]
机构
[1] Univ Belgrade, Fac Med, Belgrade 11000, Serbia
[2] Univ Clin Ctr Serbia, Clin Otorhinolaryngol & Maxillofacial Surg, Belgrade, Serbia
[3] Inst Pathol, Belgrade, Serbia
[4] Inst Oncol & Radiol Serbia, Belgrade, Serbia
[5] Inst Anat, Belgrade, Serbia
关键词
Advanced hypopharyngeal cancer; Cancer prognosis; Non-surgical treatment; Tumor volume; Survival; SQUAMOUS-CELL CARCINOMA; ADVANCED HEAD; NECK-CANCER; LARYNX CANCER; PROGNOSTIC-FACTORS; LOCAL-CONTROL; RADIOCHEMOTHERAPY; CHEMORADIATION; PRESERVATION; RADIOTHERAPY;
D O I
10.1007/s12070-024-05139-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
To determine the prognostic value of tumor volume in predicting the survival in patients with stage III-IV of hypopharyngeal carcinoma. We studied 71 patients with advanced stage of hypopharyngeal carcinoma. The volume of primary tumor was calculated by approximation of the ellipsoid volume. Correlation between carcinoma volume and demographic, clinical and carcinoma characteristics has shown that male patients and patients consuming alcohol had greater tumor volumes. The median of overall survival was at 12 months (95% CI: 9.25-14.75); the median of progression-free survival was at 9 months (95% CI: 6.6-11.3). ROC Curve Analysis of carcinoma volumes in outcome prediction shows that the cutoff of 14.69 had the sensitivity of 61% and specifics of 89%. Based on significant independent impact of tumor volume on survival, it is important to include this parameter among possible new treatment protocols.
引用
收藏
页码:184 / 193
页数:10
相关论文
共 50 条
  • [21] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study
    Roh, Jiyeon
    Eom, Jung Seop
    Lee, Min Ki
    Kim, Jehun
    Jang, Taewon
    Yoon, Seong Hoon
    Son, Choon-Hee
    Lee, Hyun-Kyung
    Kim, Hyun-Kuk
    Lee, Shin Yup
    Shin, Kyeong Choel
    Kim, Mi-Hyun
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (07): : 356 - 360
  • [22] Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study
    Feng, Ying
    Wang, Liyu
    Zhu, Fan
    Shi, Jianming
    Wang, Yan
    Zhang, Yingru
    Chen, Xiaofeng
    Zhang, Luyao
    HELIYON, 2024, 10 (05)
  • [23] Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
    Takayuki Shiroyama
    Izumi Nagatomo
    Shohei Koyama
    Haruhiko Hirata
    Sumiyuki Nishida
    Kotaro Miyake
    Kiyoharu Fukushima
    Yuya Shirai
    Yuichi Mitsui
    So Takata
    Kentaro Masuhiro
    Moto Yaga
    Kota Iwahori
    Yoshito Takeda
    Hiroshi Kida
    Atsushi Kumanogoh
    Scientific Reports, 9
  • [24] Metabolic Tumor Volume Predicts Overall Survival in Patients With Stage III Non-Small Cell Lung Cancer Treated on ACRIN 6668/RTOG 0235
    Bazan, J. G.
    Duan, F.
    Snyder, B. S.
    Horng, D.
    Graves, E. E.
    Siegel, B. A.
    Machtay, M.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S3 - S4
  • [25] Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study
    Xuefeng Yu
    Fulan Hu
    Qiang Yao
    Chunfeng Li
    Hongfeng Zhang
    Yingwei Xue
    BMC Cancer, 16
  • [26] Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study
    Yu, Xuefeng
    Hu, Fulan
    Yao, Qiang
    Li, Chunfeng
    Zhang, Hongfeng
    Xue, Yingwei
    BMC CANCER, 2016, 16
  • [27] Impact of the primary tumor metabolic volume (PT-MV) changes in the course of multimodality treatment on overall survival in patients with locally-advanced non-small cell lung cancer
    Roengvoraphoj, O.
    Wijaya, C.
    Eze, C.
    Fendler, W.
    Gerum, S.
    Belka, C.
    Manapov, F.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S109 - S109
  • [28] Impact of the primary tumor metabolic volume (PT-MV) changes in the course of multimodality treatment on overall survival in patients with locally-advanced non-small cell lung cancer
    Roengvoraphoj, O.
    Wijaya, C.
    Fendler, W.
    Eze, C.
    Gerum, S.
    Belka, C.
    Manapov, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 118 - 118
  • [29] Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
    Shiroyama, Takayuki
    Nagatomo, Izumi
    Koyama, Shohei
    Hirata, Haruhiko
    Nishida, Sumiyuki
    Miyake, Kotaro
    Fukushima, Kiyoharu
    Shirai, Yuya
    Mitsui, Yuichi
    Takata, So
    Masuhiro, Kentaro
    Yaga, Moto
    Iwahori, Kota
    Takeda, Yoshito
    Kida, Hiroshi
    Kumanogoh, Atsushi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] The Impact of VEGF Inhibition on Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy: A Retrospective Cohort Study
    Tanimura, Keiko
    Yamada, Tadaaki
    Omura, Ayaka
    Shiotsu, Shinsuke
    Kataoka, Nobutaka
    Takeda, Takayuki
    Taniguchi, Ryusuke
    Yamada, Takahiro
    Takeuchi, Mayumi
    Chihara, Yusuke
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    FRONTIERS IN ONCOLOGY, 2021, 11